Latest publication releases


    Ludewig R, Kiaei D, Plouffe B, Thompson S, Woods A, Tan S, Wang A, Pomerleau J, Grant A, Ahnadi C. Validation of a New and Improved Progesterone Assay on the IMMULITE Immunoassay .  AACC. Annual Meeting -July 17-19, 2012 in Los Angeles , CA


                  Poster "Improve Progesterone Assay" >>>


     J. Mitchell,  S. Rehel,  A. Grant, J. Weiss, A. Zaidi, M. Earing, A.M Valente, A. Gianola, A.Verstappen, G. Webb, A. Marelli, P. Khairy, D. Sahn and C. Broberg. Lessons learned from initial efforts at multicenter integration of electronic health data from adult congenital heart centers: The CONGENERATE experience.  ISCHD, June, 2012 in Toronto, Canada.

     

         View the poster presented at  ISCHD Toronto >>>




    C. Broberg, A. Gianola, J. Mitchell, J. Weiss, A.M Valente, M. Earing, A. Marelli, C. Daniels, A. Zaidi, A.Verstappen, M. Gurvitz, P. Khairy, S. Rehel, S. Cook, A. Grant, S. Crumb, G. Webb, D. Sahn. A Specific Health Information  System for Adult Congenital Heart Disease Integrated With Electronic Health Records Can Facilitate Multicenter Research.  ACC. 12 Scientific Sessions - Moderated Poster Session, Sunday, March 25, 2012 in Chicago, IL

     

         View the REACH poster presented at ACC 2012 >>>



    Weiss JB, Grant A, Marelli A, Khairy P, Maurais T, Rehel S, Chetaille P, Broberg CS. 
    Assessment of Electronic Health Information System Use and Need in US Adult Congenital 

    Heart Disease Centers 

    Congenit Heart Dis 2011 Mar;6(2):134-8. doi: 10.1111/j.1747-0803.2011.00498.x. Epub 2011 Mar 21.
         

      

 View the Abstract >>>


Posters

 

1.      Ludewig R, Kiaei D, Plouffe B, Thompson S, Woods A, Tan S, Wang A, Pomerleau J, Grant A, Ahnadi C. Validation of a New and Improved Progesterone Assay on the IMMULITE Immunoassay .  AACC. Annual Meeting -July 17-19, 2012 in Los Angeles , CA.

2.      J. Mitchell,  S. Rehel,  A. Grant, J. Weiss, A. Zaidi, M. Earing, A.M Valente, A. Gianola, A.Verstappen, G. Webb, A. Marelli, P. Khairy, D. Sahn and C. BrobergLessons learned from initial efforts at multicenter integration of electronic health data from adult congenital heart centers: The CONGENERATE experience.  ISCHD, June, 2012 in Toronto, Canada.

3.      C. Broberg, A. Gianola, J. Mitchell, J. Weiss, A.M Valente, M. Earing, A. Marelli, C. Daniels, A. Zaidi, A.Verstappen, M. Gurvitz, P. Khairy, S. Rehel, S. Cook, A. Grant, S. Crumb, G. Webb, D. Sahn. A Specific Health Information  System for Adult Congenital Heart Disease Integrated With Electronic Health Records Can Facilitate Multicenter Research.  ACC. 12 Scientific Sessions - Moderated Poster Session, Sunday, March 25, 2012 in Chicago, IL

4.      A.Grant, B. de Faria, L.de Faria,  P.Whitaker, A.Fleury, S.Rehel.  Improving Access to Knowledge about HealthInformatics  Standards: Considerations for HealthInformation System  Implementations In Low Income Countries.CDC Health Informatics Conf. 2011,  Atlanta.

5.      Rechner AR, Merz M, Christie D, Giannitsis E, Rade J, Kickler T, Parades F, Ahnadi C, de Filippi C, Christenson RH, Shah A, McGlasson D. Comparison of the detection of P2Y12-receptor blockade in cardiovascular disease patients by whole blood aggregometry, classic light transmittance aggregometry and INNOVANCE® PFA P2Y. GTH-congress, February 24-27, 2010, Nuremberg, Germany.

6.      Rechner AR, Merz M, Christie D, Giannitsis E, Rade J, Kickler T, Parades F, Ahnadi C, de Filippi C, Christenson RH, Shah A, McGlasson D. Detection of P2Y12-receptor blockade in cardiovascular disease patients using INNOVANCE® PFA P2Y* for the PFA-100® system. GTH-congress, February 24-27, 2010, Nuremberg, Germany.

7.      Essadiqi B, Ahnadi CE, Grant A, Lepage S.  Diagnostic Utility of B-Natriuretic Peptide in Evaluation of Diastolic Dysfunction. Journal of Cardiac Failure, Volume 15, Issue 6, Supplement 1, August 2009, Page S71

8.      Ahnadi, C, Pomerleau, J, Leonard, M, Ludewig, R, Tan, S, Canfield, W, Martel, J, Grant, A. Validation of the Centaur Sex Hormone Binding Globulin (SHBG)* Immunoassay using the ADVIA Centaur System. American Association of Clinical chemistry, Annual meeting, July 19-23, 2009, Chicago, Illinois, USA.

9.      Ahnadi, C, Essadiqi, B, Grant, A, Lepage, S.Diagnostic utility of B-Natriuretic Peptide in evaluation of diastolic dysfunction. American Association of Clinical chemistry, Annual meeting, July 19-23, 2009, Chicago, Illinois, USA.

10.   W. Kelley, C. Ahnadi, J. Gray, J.F. Pomerleau, S.E. Mongomery-Chapman,J. Fan, S. Tan, R. Levine, S.P. Volkir, A. Grant, R.H. Christenson. A Multi-Center Evaluation of the Clinical Performance of the ADVIA Centaur® Free PSA. Assay American Association of Clinical chemistry, Annual meeting, July 19-23, 2009, Chicago, Illinois, USA.

11.   Essadiqi B, Ahnadi CE, Grant A, Lepage S. Utility of B-Natriuretic Peptide in evaluation of diastolic dysfunction Canadian Cardiovascular Congress 2008, October 25-29, Toronto, Ontario, canada

12.   Dillon P, Ahnadi CE, Grant A,  Delaney C,  Schiff E,  Okorodudu A,  Omoruyi F,  Anostario M, Bauer R, Saxton C. A Multi-Center Evaluation of the Analytical Performance of the ADVIA Centaur Hepatitis Assays on the ADVIA Centaur CP Immunoassay System. American Association of Clinical chemistry, Annual meeting, July 27-31, 2008, Washington DC, USA

13.   Ahnadi,  C.E.,  Pomerleau,  J.F,  Chapman-Montgomery,  S.  and Grant,  A.M. Evaluation of the anticoagulants EDTA containing Disodium Diazolidyl Urea to prevent unsolicited platelet activation. American Association of Clinical chemistry, Annual meeting, July 15-19, 2007, San Diego, CA, USA.

14.   Ahnadi, C.E., Pomerleau, J.F, Martel, J. and Grant,  A.M. Evaluation of the performance of the TnI-UltraTM Troponin assay on the ADVIA Centaur® CP system. Canadian Society of Clinical Chemistry, 51st annual meeting, June 9-13, 2007, Toronto, Canada.

15.   Ahnadi, C.E., Pomerleau, J.F, Chapman-Montgomery, S. and Grant,  A.M.  Evaluation of the anticoagulants EDTA containing Disodium Diazolidyl Urea to prevent unsolicited platelet activation. XXIst Congress of the International Society on Thrombosis and Haemostasis (ISTH) July 6 - 12 2007, Geneva, Switzerland.Journal of thrombosis and Haemostasis vol 5, S 1, pp322.

16.   Ahnadi, C.E., Pomerleau, J.F, Chapman-Montgomery,  S. and Grant,  A.M.  Effect of the anticoagulants EDTA containing Disodium Diazolidyl Urea on unsolicited platelet activation. Canadian Society of Clinical Chemistry, 51st annual meeting, June 9-13, 2007, Toronto, Canada.

17.   Ahnadi, CE, Pomerleau, JF, Levine, R, Tan, S, Grant, A.  Analytical evaluation of B-type natriuretic peptide (BNP) on the ADVIA IMSÒ 800i system. American Association of Clinical chemistry, 58td Annual meeting, July 23-27, 2006, Chicago, Illinois, USA. Clinical Chemistry Vol. 42, S.6, pp A122

18.   Ahnadi, CE, Pomerleau, JF, Levine,  R, Tan, S, Grant, A. Evaluation of the performance of a third-generation TnI-UltraTM assay on the ADVIA IMSÒ 800i system. American Association of Clinical chemistry, 58td Annual meeting, July 23-27, 2006, Chicago, Illinois, USA. Clinical Chemistry Vol. 42, S.6, pp A122.

19.   Leboeuf R, Langlois MF, Martin M, Ahnadi CE, Guy Fink. Réponse inappropriée ou effet crochet lors du dosage de calcitonine chez un patient atteint d’un carcinome médullaire de la thyroïde. Annales de Biologie Clinique du Québec 2005;42(3)28.

20.   Ahnadi CE, Lepage S, Leclair C, Grant A. Marginal effect of interference of simvastatin on clopidogrel antiplatelet effectiveness assessed by measures of platelet activation and aggregation. Journal of Thrombosis and Haemostasis 2005, vol. 3 (1): P2144.

21.   Ahnadi, C.E. , Gheorghiu I. , Lepage R. , Beaulieu M., Grant, A. Comparison of bioavailable testosterone determined by precipitation and calculation using three automated systems. IFCC/AACC, XIX Annual meeting, July 24-28, 2005, Orlondo, FL, USA.

22.   Ahnadi CE, Lepage S, Leclair C, Grant A. Marginal effect of interference of simvastatin on clopidogrel antiplatelet effectiveness assessed by measures of platelet activation and aggregation. IFCC/AACC, XIX Annual meeting, July 24-28, 2005, Orlondo, FL, USA.

23.   Ahnadi C. E., Boughrassa F., Chapman S., Poisson V., Gervais A., Okrongly D. and Grant A.Comparison of two methods to assess variability of platelet response to anti-platelet therapies in patients with acute coronary syndrome undergoing angioplasty. Clinical Laboratory 2005, 51:208-209.

24.   Ahnadi, C.E., Boughrassa, F., Chapman, E.S., Okrongly, D., Grant, A.M. Basal platelet activation and C-reactive protein levels and relationship in patients with acute coronary syndrome. American Association of Clinical chemistry, 56th Annual meeting, July 25-29, 2004, Los Angeles, CA, USA.

25.   Gheorghiu,  I.,  Ahnadi,  C.E.,  Lepage R., Hoang,  T., and  Grant, A.M. Indirect, automated method for measurement of bioavailable testosterone after precipitation. American Association of Clinical chemistry, 56th Annual meeting, July 25-29, 2004, Los Angeles, CA, USA. Clin Chem 2004; 50:A85.

26.   Ghani, F, A. Wu, A, Bijou, R, Packer, M, Haverstick, DM, Feldkamp, CS, Thiel, R, Ahnadi, CE, Mair, J, Johnston , N, Mindicino, H, Conarpe, C. BNP Levels in Heart Failure for Individuals with Diabetes, Hypertension, COPD, or Renal Disease. American Association of Clinical chemistry, 56th Annual meeting, July 25-29, 2004, Los Angeles, CA, USA.

27.   Gheorghiu,  I.,  Ahnadi,  C.E.,  Lepage R., Hoang,  T., and  Grant, A.M. Measurement of bioavailable testosterone after precipitation by an indirect, automated method. Canadian Society of Clinical Chemistry, 48rd annual meeting, June 5-10, 2004, London, ON, Canada.

28.   Ahnadi, C.E., Boughrassa, F., Grant, A.M. Basal platelet activation and C-reactive protein levels and relationship in patients with acute coronary syndrome.  National Research Forum for Young Investigators in Circulatory and Respiratory Health, May 6-9, 2004,Winnipeg, Manitoba, Canada. Exp Clin Cardiol 2004, Vol9, pp 35.

29.   Grant A., Moshyk A., Diab H., Caron P., de Lorenzi F., Desautels M.Integrating Feedback from a Clinical Datawarehouse into Practice Organisation, Euromise 2004, 12-15 avril 2004, Prague.

30.   Ahnadi, C.E., Boughrassa, F., Chapman, E.S., Okrongly, D., Grant, A.M. Preoperative platelet activation and C-reactive protein levels and relationship in patients with acute coronary syndrome. American Society of Hematology, 45th Annual meeting,December 6-9, 2003, San Diego, CA, USA, , Blood, Vol 102.

31.   Ghani, F, A. Wu, A, Bijou, R, Haverstick, DM, Feldkamp, CS, Thiel, R, Grant, A, Ahnadi, CE, Mair, J, Despres, N, Mindicino, H, Conarpe, C, Packer, M. Circulating Levels of B-type Natriuretic Peptide (BNP) are Useful for Diagnosis and are Associated with Severity of Symptoms in Chronic Heart Failure: Preliminary Data from a Multicenter Study with Bayer ADVIA ® Centaur BNP Assay. American Association of Clinical chemistry, 55th Annual meeting, July 20-24, 2003, Philadelphia, PA, USA. Clinical Chemistry 2003, Vol. 49, No.6, pp A67.

32.   Gheorghiu,  I.,  Ahnadi,  C.E.,  Lepage R., Hoang,  T., and  Grant, A.M. An automated method for the determination of salivary testosterone. American Association of Clinical chemistry, 55th Annual meeting, July 20-24, 2003, Philadelphia, PA, USA. Clinical Chemistry 2003, Vol. 49, No.6, pp A131.

33.   Ahnadi, C.E., Boughrassa, F., Chapman, E.S., Lachance J., Dumont, G., Grant, A.M. Relation between platelet activation and inflammation in patients with acute coronery syndrome. Canadian Society of Clinical Chemistry, 47rd annual meeting, June 1-5, 2003, Saint-Sauveur, Qc, Canada.

 

34.   Gheorghiu, I.,  Ahnadi,  C.E.,  Lepage R., Hoang,  T., and  Grant, A.M. Adaptation of an automated serum testosterone method to saliva. Canadian Society of Clinical Chemistry, 47rd annual meeting, June 1-5, 2003, Saint-Sauveur, Qc, Canada.

35.   Goldblatt J, Mindicino H, Gupta M., Ahnadi C.E., Jialal I.: Clinical evaluation of the Bayer ADVIAâ CentaurÔ  and ACS: 180 Homocysteine assays. Clinical Ligand Assay Society, 29th meeting, May 7-10, 2003, Baltimore, MD, USA.

36.   Caron, P., Desautels M., de Lorenzi. F, Grant, A., Gestion de l'information en santé: de la Collection des Données, par sa Gestion vers la Livraison de l'Information. 10e Journées Francophones d'informatique médicale, Tunis 2003.

37.   Djaider, L, Moshyk, A, Giroux, S, Caron, P , Nguyen M, Grant, AAnalyse sur la mise en place d'un cadre d'application supportant les médecins dans la modélisation et la résolution de problèmes cliniques. 10e Journées Francophones d'informatique médicale, Tunis 2003

38.   Caron, P., Grant, A., Leblanc, F., Jari, J., Didacticus, a multi dimensional Online learning environment, IMIA Working Group for Education Conference 2003 Teach Globally, Learn Locally: Innovations in Health and Biomedical Informatics Education in the 21st Century, Portland, Oregon, USA.

39.   Lepage, S., Ahnadi, C.E., Lucena-Fernandes, F., Kelly, A. , Grant, A.: Role of Cardiac Markers in Patients with Unstable Angina at Intermediate Risk. Canadian Cardiovascular Congress 2002, October 26-30, 2002, Edmonton, Alberta, Canada.

40.   Ahnadi, C.E., Boughrassa, F., Chapman, E.S.,  Poisson V., Gervais A., Lépine M., Lachance J. Dumont, G., Grant, A.M.: Monitoring the effect of anti-platelet agents on the platelet count and function using the automated ADVIAÒ120 Hematology System. American Association of Clinical chemistry, 54rd Annual meeting, July 28-August 1, 2002, Orlando, Florida, USA. Clinical Chemistry Vol. 48, No.6, pp A112.

41.   Ahnadi, C.E., Sabourin A., Langlois M.F.  , Lachance, J.F., Dumont G., Lepage R., Grant, A.M. : Biological day-to-day variation of salivary and serum cortisol in healthy donors. American Association of Clinical chemistry, 54rd Annual meeting, July 28-August 1, 2002, Orlando, Florida, USA. Clinical Chemistry Vol. 48, No.6, pp A136

42.   Ahnadi, C.E., Lachance, J.F., Dumont, G., Dillon, P.W., Tan, S., Readio, J., Barbarakis, M., Grant, A.M.: Clinical evaluation of Vancomycin and Theophylline 2 on the ADVIA CentaurÒ and ACS:180Ò systems.  American Association of Clinical chemistry, 54rd Annual meeting, July 28-August 1, 2002, Orlando, Florida, USA. Clinical Chemistry Vol. 48, No.6, pp A51

43.   Ahnadi, C.E., Lachance, J.F., Dumont, G., Saxton, C., Grant, A.M. : Clinical Evaluation of the CA 15-3® Assay on the ADVIA CentaurÒ System. American Association of Clinical chemistry, 54rd Annual meeting, July 28-August 1, 2002, Orlando, Florida, USA. Clinical Chemistry Vol. 48, No.6, pp A27

44.   Ahnadi, C.E., Boughrassa, F., Chapman, E.S., Lachance J., Dumont, G., Grant, A.M. : Platelet activation variability in patient response to Clopidogrel and abciximab. International Society of Animal Clinical Biochemistry, June 18-22, 2002, Gainesville, Florida, USA.

45.   Benchakroun, A., Caron, P., Dion, J-G, A One-dimensional Cutting Stock Problem: Exact and approximate solutions for the global problem, CIRO'02, Marrakech 2002.

46.   Caron, P., Benchakroun, A., Dion, J-G, A One-dimensional Cutting Stock Problem: Exact algorithms for minimising the total loss and the number of set-ups, JOPT 02, Montral 2002.

47.   Caron, P., Benchakroun, A., Dion, J-G, A One-dimensional Cutting Stock Problem : Exact and approximate solutions for the knife's moves problem, JOPT 02, Montral 2002.

48.   Ahnadi, C.E., Boughrassa, F., Poisson V., Chapman, E.S.,  Gervais A., Lépine M., Lachance J., Dumont, G., Grant, A.M.: Monitoring the Effect of anti-platelet agents on the Platelet count using the automated ADVIA®120 Hematology System. American Society of Hematology, 43rd Annual meeting,December 7-11, 2001, Orlando, Florida, USA,  Blood, Vol 98, number 11, 2001, p254a.

49.   Ahnadi, C.E., Boughrassa, F., Poisson V., Chapman, E.S.,  Gervais A., Lépine M., Lachance J., Dumont, G., Grant, A.M.:  Platelet activation variability in Patient response to Abciximab and clopidogrel. Blood, Vol 98, number 11, 2001, p254a

50.   Ahnadi, C.E., Poisson V., Chapman, E.S., Gervais A., Lepine M., Boughrassa, F., Lachance J., Dumont, G., Grant, A.M. : Evaluation of platelet activation for monitoring the anti-platelet effects of Clopidogrel and ReoPro. American Association of Clinical chemistry, 53rd Annual meeting, July 26-August 2, 2001, Chicago, Illinois, USA. Clinical Chemistry Vol. 47, No.6, pp A173.

51.   Lepage, S., Ahnadi, C.E., Lucena-Fernandes, F., Kelly, A., Armstrong, G., Ghani, F., Grant, A. Role of cardiac markers in patients with unstable angina at intermediate risk. American Association of Clinical chemistry, 53rd Annual meeting, July 26-August 2, 2001, Chicago, Illinois, USA. Clinical Chemistry Vol. 47, No.6, pp A214.

52.   Ahnadi, C.E., Poisson V., Chapman, E.S.,  Gervais A., Lepine M., Boughrassa, F., Lachance J., Dumont, G., Grant, A.M. : Platelet activation evaluation for anti-platelet therapy monitoring using the automated ADVIA 120 Hematology System. International Society on Thrombosis and Haemostasis, July 6-12, 2001, Paris, France.

53.   Lepage, S., Ahnadi, C.E., Lucena-Fernandes, F., Kelly, A., Armstrong, G. , Ghani, F., Kaplan, I., Grant, A. : Performance of cardiac markers and ECG in relation to the Braunwald classification of unstable angina. Clinical Ligand Assay Society,27th meeting, May 16-19, 2001, Detroit, MI, USA.

54.   Benchakroun, A., Caron, P., Dion, J-G, Exact Algorithms for the Global One-dimensional Cutting problem, Optimization 2001, Aveiro, juillet 2001.

55.   Caron, P., Benchakroun, A., Dion, J-G, Algorithmes efficaces pour la résolution exacte du problème global de coupe unidimensionnelle, SCRO-JOPT, Québec, mai 2001.

56.   Ahnadi, C.E: Potential use of new parameters of Platelet activation in clinical applications. XIIIth International Symposium on Technological Innovations in Laboratory Hematology, April 12-16, 2000, Banff, Canada - Invited Speaker, 2000.

57.   Ahnadi C.E., Chapman E.S., Hoang T., Lucena-Fernandes F., and Grant A.M.: Evaluation of platelet activation in patient with chest pain by the Advia 120 hematology system, American Association of Clinical chemistry. 52nd Annual meeting, July 23-27, 2000, San Fransisco, CA, USA

58.   Ahnadi C.E., Lachance J.F., Préville M., Martel J., Grant A.M.: Effective adaptation of an available automated method for serum cortisol in order to measure salivary cortisol. American Association of Clinical chemistry, 52nd Annual meeting, July 23-27, 2000, San Fransisco, CA, USA.

59.   Boughrassa F.F., Ahnadi C.E., Poisson V., Chapman E.S., Grant A.M. : Comparaison de l’effet de différents anticoagulants sur l’activation des plaquettes in vitro .Club de Recherche Clinique.42ème réunion annuelle. Septembre 2000. Bromont,Qc,Canada.

60.   Lucena-Fernandes F., Lepage S., Kelly A., Armstrong G., Ahnadi C.E., Lachance J.F., Grant A.M. : Correlation of Troponin I, Troponin T, CK-MB, ECG and Severity of Unstable Angina. American Association of Clinical chemistry. 52nd Annual meeting, July 23-27, 2000, San Fransisco, CA, USA.

61.   Ahnadi C.E., Chapman E.S., Okrongly D., Hoang T., Lucena-Fernandes F., and Grant A.M. : Evaluation of Platelet Activation in Patients with Chest Pain by the ADVIA 120 Hematology System. The Fifth International Bayer Diagnostics Laboratory Symposium, June 25-27, 2000, Seville, Spain.

62.   Lucena-Fernandes F., Lepage S., Kelly A., Armstrong G., Ahnadi C.E., Lachance J.F., Grant A.M. : Correlation of Troponin I, Troponin T, CK-MB, ECG and Severity of Unstable Angina. 44th Annual CSCC-CAMB-AACC conference, June 3-7, 2000, Hamilton, Ontario, Canada. Clinical Biochemistry Vol. 33 (3), pp 228.

63.   Ahnadi C.E., Lachance J.F., Martel J., Grant A.M.: Effective adaptation of an available automated method for serum cortisol in order to measure salivary cortisol. 44th Annual CSCC-CAMB-AACC conference, June 3-7, 2000, Hamilton, Ontario, Canada. Clinical Biochemistry Vol. 33 (3), pp 225.

64.   Ahnadi C.E., Chapman E.S., Hoang T., Lucena-Fernandes F., and Grant A.M.: Evaluation of platelet activation in patient with chest pain. 9th Arab congress of Clinical Biology & International Federation of Clinical Chemistry and Laboratory Medicine. May 3-6, 2000, Rabat, Morocco.

65.   Ahnadi C.E., Chapman E.S., Hoang T., Lucena-Fernandes F., and Grant A.M.: Evaluation of platelet activation in patient with chest pain by the Advia 120 hematology system. XIIIth International Symposium on Technological Innovations in Laboratory Hematology, April 12-16, 2000, Banff, Canada.

66.   Massé M., Ahnadi C.E., Gagné E., Dufresne J., Letendre S., Grant A.: Estblishment of characteristics reticulocyte hemoglobin content (CHr) reference ranges and comparison of two IV maintenance iron regimes in hemodialysis patients. Meeting of the Canadian Society of Nephrology, March 2000, Montreal, Canada.

67.   Poisson V., Boughrassa F., Amar Bensaber B., Hoang T., Lachance J.F., Ahnadi C.E., Grant A.M.: Utilité d'un site web dans la recherche évaluative multisite. 2e Colloque sur l'informatique appliquée à la recherche biomédicale et clinique, 2-3 mars 2000, Sherbrooke, Québec.

68.   Amar Bensaber B, Couture L, Tremblay N, Drapeau D, Blanchette D, Arsenault S, Maheux P, Gagné C, Gaudet D, Grant A.M. PIERCE : Prototypage Informatique en Recherche Clinique. Club de Recherche Clinique. 42ème réunion annuelle. Septembre 2000. Bromont, Qc, Canada

69.   Leblanc F, Grant A.M et al. Implémentation des lignes directrices cliniques - Facteurs influençant la vitesse d'introduction d'un nouveau test diagnostique. Club de Recherche Clinique. 42ème réunion annuelle. Septembre 2000. Bromont, Qc, Canada.

70.   Bolduc L, Grant A.M et al. Amélioration de l'évidence et des mécanismes de pro-action et de rétroaction dans le développement de nouvelles technologies de diagnostic en biomédecine. Club de Recherche Clinique. 42ème réunion annuelle. Septembre 2000. Bromont, Qc, Canada.

71.   Amar Bensaber B., Couture L., Tremblay N., Drapeau D., Blanchette D., Arsenault S., Maheux P., Gagné C., Gaudet D., et Grant A.M.PIERCE Programme: Informatics Support for Multisite Clinical Research. Infocus 2000, Vancouver, British Columbia, Canada.

72.   Amar Bensaber B., Couture L., Tremblay N., Drapeau D., Blanchette D., Arsenault S., Maheux P., Gagné C., Gaudet D., et Grant A.M.PIERCE : Prototypage Informatique en Recherche Clinique. 8eJournées Francophones d'Informatique Médicale, 30-31 mai 2000, Marseille, France.

73.   Grant A.M. Clinicians use of report cards and information for accountability : mixing mismatched expectations. HEALNet Network of Centres of Excellence Annual Meeting - Invited Speaker, 2000.

74.   Amar Bensaber B., Couture L., Tremblay N., Drapeau D., Blanchette D., Arsenault S., Maheux P., Gagné C., Gaudet D., et Grant A.M.PIERCE : Prototypage Informatique en Recherche Clinique. 2eè Colloque sur l'informatique appliquée à la recherche biomédicale et clinique, 2-3 mars 2000, Sherbrooke, Québec.

75.   Ahnadi C.E., Masse M., Gagné E., Dufresne J., Letendre S., Lachance J., Grant A.M. : Reticulocyte hemoglobin content as a sensitive marker of functional iron deficiency in hemodialysis patients: establishment of characteristic CHr reference ranges and comparison of two low-dose intravenous maintenance iron regimes. American Society of Nephrology, 32nd Annual meeting, November 5-8, 1999.

76.   Masse M., Ahnadi C.E., Langlois N., Letendre S., Gagné E.-R., Dufresne, J., Lachance J., Langley R., Grant A.M. : Étude comparant deux modalités d'administration de petites doses de fer Dextran en thérapie de maintenance chez les patients hémodialysés chroniques. Mesure des différents paramètres de suivi des réserves de fer et d'un nouveau marqueur (CHr) contenu en hémoglobine réticulocytaire comme marqueur de la déficience fonctionnelle en fer. Société de Néphrologie et Société Francophone de Dialyse, 6-8 octobre 1999, Lausanne, Suisse.

77.   Ahnadi C.E., Lepine M., Lambert G., Chapman E.S. and Grant A.M.: Comparison of in vitro platelet activation in blood collected into sodium citrate, EDTA or Diatube-H., American Association of Clinical chemistry. 51st Annual meeting, July 25-29, 1999, New Orleans, Louisiana, USA. Clinical Chemistry Vol. 45, No.6, pp A60.

78.   Ahnadi C.E., Lachance J.F., Fink G., Grant A.M.: Third Generation TSH assay performance on the Bayer Immuno 1® system, International Federation of Clinical chemistry and Laboratory Medicine. 1999 annual meeting, June 6-11, Firenze, Italy. Clinical chemistry and Laboratory Medicine Vol.37, pp 171.

79.   Ahnadi C.E., Lepine M., Lambert G., Chapman E.S. and Grant A.M.: Comparison of in vitro platelet activation in blood collected into sodium citrate vs CTAD. International Federation of Clinical chemistry and Laboratory Medicine, 1999 annual meeting, June 6-11, Firenze, Italy. Clinical chemistry and Laboratory Medicine Vol.37, pp 200.

80.   Ahnadi C.E., Lachance J.F., Fink G. and Grant A.M.: Third Generation TSH assay performance on the Bayer Immuno 1® system. Canadian Society of Clinical Chemistry, 43rd annual meeting, May 8-13, 1999, Winnepeg, Alberta Canada.

81.   Ahnadi C.E., Lepine M., Lambert G., Chapman E.S. and Grant A.M.: Effects of sodium citrate and CTAD anticoagulants on platelet activation in vitro. Canadian Society of Clinical Chemistry, 43rd annual meeting, May 8-13, 1999, Winnepeg, Alberta Canada.

82.   Martel J., Després N., Lachance J.-F., Dillon P.W., Grant A.M.Evaluation of the Procainamide Assay on the Bayer Immuno 1 System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists. 1998 Annual Meeting, August 4-6, Chicago, IL.

83.   Després N., Martel J, Lachance J.-F., Fink G.D., Monticello J., Grant A.M. Evaluation of the Analytical Performance of the Bayer Immuno 1® and Chiron ACS:180® Thyroid Panels. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists. 1998 Annual Meeting, August 4-6, Chicago, IL.

84.   Martel J., Després N., Lachance J.-F., Dillon P.W., Grant A.M.Evaluation of the N-Acetylprocainamide (NAPA) Assay on the Bayer Immuno 1® System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 1998 Annual Meeting, August 4-6, Chicago, IL.

85.   Martel J., Després N., Dillon P.W., Carpenter W., Grant A.M.Evaluation of the CA 72-4 Assay on the Bayer Immuno 1 System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists. 1998 Annual Meeting, August 4-6, Chicago, IL.

86.   Martel J., Després N., Lachance J.-F., Fink G.D., Monticello J.E., Grant A.M. Evaluation of the Analytical Performance of the Bayer Immuno 1 and Chiron ACS:180 Thyroid Panels. Canadian Society of Clinical Chemists & Canadian Association of Medical Biochemists, Annual Meeting, Ottawa, June 14-18, 1998.

87.   Martel J., Després N., Lachance J.-F., Dillon P.W., Grant A.M.Evaluation of the Procainamide Assay on the Bayer Immuno 1 System. Canadian Society of Clinical Chemists & Canadian Association of Medical Biochemists, Annual Meeting, Ottawa, June 14-18, 1998.

88.   Martel J., Després N., Lachance J.-F., Dillon P.W., Grant A.M.Evaluation of the N-Acetylprocainamide (NAPA) Assay on the Bayer Immuno 1 System. Canadian Society of Clinical Chemists & Canadian Association of Medical Biochemists, Annual Meeting, Ottawa, June 14-18, 1998.

89.   Xhignesse M., Laplante P., Niyonsenga T., Delisle E., Vanasse N., Grant A.M, Bernier R. Physician knowledge of patient lipoprotein profiles : Analysis of the FAMUS database. 4th International Conference on Preventive Cardiology. Montréal, Québec, 29 juin au 3 juillet 1997. Can J. Cardiol Vol 13 Suppl B June 1997, p. 292B.

90.   Xhignesse M., Grant A.M, Laplante P., Niyonsenga T., Delisle E., Charlin B., Grand'Maison P. From FAMUS to PRIMUS : Review of a five year network experience and future orientations. 1997 ACTH-CAME Annual Meeting. Halifax, Nova Scotia, 3-7 mai 1997.

91.   Niyonsenga T., Xhignesse M., Vanasse N., Laplante P., Grant A.M.Time related practice variation : Effects of physician interventions on some cardiovascular disease risk factors. 1997 CDC and ATSDR Symposium on Statistical Methods, Atlanta, Georgia, 29-30 janvier 1997.

92.   Xhignesse M., Laplante P., Niyonsenga T., Delisle E., Vanasse N., Bernier R., Grant A.M. Secondary prevention of CVD : Are we doing enough? Analysis of the FAMUS database. 25e Assemblée annuelle de NAPCRG. Orlando, Floride, USA. 12 au 15 novembre 1997.

93.   Laplante P., Xhignesse M., Niyonsenga T., Delisle E., Grant A.M., Vanasse N. Traitement en monothérapie de l'hypertension non compliquée par un groupe d'omnipraticiens du Québec. Données du registre provincial FAMUS. 1er Colloque du réseau FRSQ sur l'utilisation des médicaments. Montréal, Québec, 16-17 juin 1997.

94.   Laplante P., Xhignesse M., Niyonsenga T., Delisle E., Grant A.M., Vanasse N. Traitement en monothérapie de l'hypertension non compliquée par un groupe d'omnipraticiens du Québec. Données du registre provincial FAMUS, 9e Journée québécoise de la recherche en médecine familiale. Montréal, Québec, 13 juin 1997.

95.   Laplante P., Niyonsenga T., Delisle E., Vanasse N., Bernier R., Grant A.M., Xhignesse M. Treatment of dyslipidemias : Five years of Evolution in the FAMUS Network. Conférence 97 Société canadienne d'épidémiologie et de biostatistiques. London, Ontario, 25-28 mai 1997.

96.   Richard Y., Dagenais A., Buteau M., Deland E., Gauthier S., Mehta V., Grant A.M. The use of an executive information system tool in interaction with the electronic medical record as a source of dynamic feedback for the clinical professional - a study forming part of the Autocontrol Project. HEALNet Annual General Meetings, November 13-15, Toronto, Ontario, 1997.

97.   Gauthier S., Richard Y., Mehta V., Deland E., de Lorenzi F., Veilleux M., Buteau M., Grant A.M. Examining the use of internal and external evidence in the process of decision making for a change in the practice of use of blood gases in the surgical intensive care unit - a study forming part of the Autocontrol Project. HEALNet Annual General Meetings, November 13-15, Toronto, Ontario, 1997.

98.   Mehta V., Kushniruk A., Gauthier S., Richard Y., Deland E., Veilleux M., Patel V., Grant A.M. The efficient use of information by the professional team of a clinical unit to obtain consensus for practice change - a study forming part of the Autocontrol Project. HEALN et Annual General Meetings, November 13-15, Toronto, Ontario, 1997.

99.   Grant A.M., Richard Y., Deland E., Després N., Buteau M. Involving Clinicians in Managerial Decision Making Annual Meeting CAME, Halifax, May 3-7, 1997.

100.          Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the Quinidine Assay on the Bayer Technicon Immuno 1 System. 41st Annual Meeting of the Canadian Society of Clinical Chemists, Halifax, NS, 6-10 July, 1997.

101.          Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the Carbamazepine Assay on the Bayer Technicon Immuno 1 System. 41st Annual Meeting of the Canadian Society of Clinical Chemists, Halifax, NS, 6-10 July, 1997.

102.          Martel J., Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the Valproic Acid Assay on the Bayer Technicon Immuno 1 System. 41st Annual Meeting of the Canadian Society of Clinical Chemists, Halifax, NS, 6-10 July, 1997.

103.          Martel J., Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the Vancomycin Assay on the Bayer Technicon Immuno 1 System. 41st Annual Meeting of the Canadian Society of Clinical Chemists, Halifax, NS, 6-10 July, 1997.

104.          Richard Y., Buteau M., Deland E., Després N., Grant A.M. Autocontrol for Optimizing Test Use - A Partnership Between Laboratory Professionals and Clinical Decision Makers. 41st Annual Meeting of the Canadian Society of Clinical Chemists, Halifax, NS, 6-10 July, 1997.

105.          Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the Quinidine Assay on the Bayer Technicon Immuno 1 System. American Association for Clinical Chemistry. 49th Annual Meeting, 20-24 July 1997, Atlanta, GA. Clin Chem 1997;43:S208.

106.          Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the Carbamazepine Assay on the Bayer Technicon Immuno 1 System. American Association for Clinical Chemistry, 49th Annual Meeting, Atlanta, GA, 20-24 July. Clin Chem 1997;43:S208.

107.          Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the Valproic Acid Assay on the Bayer Technicon Immuno 1 System. American Association for Clinical Chemistry, 49th Annual Meeting, Atlanta, GA, 20-24 July. Clin Chem 1997;43:S208.

108.          Després N., Dillon P.W., Garland D., Grant A.M. Evaluation of the Vancomycin Assay on the Bayer Technicon Immuno 1 System. American Association for Clinical Chemistry, 49th Annual Meeting, Atlanta, GA, 20-24 July. Clin Chem 1997;43:S208.

109.          Xhignesse M., Niyonsenga T., Delisle E., Vanasse N., Laplante P., Grant A.M., Bernier R. Cardiovascular risk and the use of hormone replacement therapy by women 55 years of age and over : Analysis of the FAMUS primary care register. 11e réunion du Réseau canadien de santé du coeur, Calgary Alberta, 23-25 mai 1996.

110.          Xhignesse M., Niyonsenga T., Delisle E., Vanasse N., Laplante P., Grant A.M., Bernier R. Cardiovascular disease and the use of hypolipidemic agents in individuals 65 years of age or over : Analysis of the FAMUS primary care register. 11e réunion du Réseau canadien de santé du coeur, Calgary, Alberta, 23-25 mai 1996.

111.          Grant A.M, Xhignesse M., Buteau M., Oumar B.A., Richard Y., Després N., Léonard K. Methodologies for evaluation research in the clinical setting. 1996 International health evaluation association. Victoria, British Columbia, 9-12 octobre 1996.

112.          Laplante P., Vanasse A., Xhignesse M., Grant A.M., Bernier R.Observance des médecins de famille au Consensus canadien sur l'hypertension face à la notation de la tension artérielle. Présentation orale, 8e Journée de la recherche en médecine familiale. Sherbrooke, Québec, 10-14 juin 1996.

113.          Xhignesse M., Niyonsenga T., Delisle E., Vanasse N., Laplante P., Grant A.M., Bernier R. Prévalence de l'hormonothérapie de remplacement chez les femmes âgées de 55 ans ou plus selon le registre FAMUS. Présentation par affiche, 8e Journée de la recherche en médecine familiale. Sherbrooke, Québec, 10-14 juin 1996.

114.          Xhignesse M., Niyonsenga T., Delisle E., Vanasse N., Laplante P., Grant A.M., Bernier R. Maladies cardiovasculaires et utilisation des agents hypolipidémiants chez les individus âgés de 65 ans et plus : une analyse du registre de soins primaires FAMUS. Présentation orale, 12e Congrès de la Société québécoise de gériatrie Québec, Québec, 30 mai au 1er juin 1996.

115.          Lévesque A., Letellier M., Grant A.M. évaluation analytique de l'essai pour le dosage de la testostérone totale sur l'autoanalyseur Technicon Immuno 1 de Bayer. SQBC Annual Meeting, September 11-14, 1996.

116.          Fortin C., Després N., Letellier M., Grant A.M. élévation non-spécifique de la thyroxine libre en présence d'autoanticorps anti-thyroxine. SQBC Annual Meeting, September 11-14, 1996.

117.          Letellier M., Lévesque A., Daigle F., Grant A.M. Performance Evaluation of Automated Immunoassays on the Technicon Immuno 1 System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 48th Annual Meeting, July 28-August 1, Chicago, IL. Clin Chem 1996;42:S142.

118.          Letellier M., Lévesque A., Dillon P.W., Grant A.M. Determination of the Reference Ranges for FSH, LH, Estradiol and Progesterone in Normal Cycling Females on the Bayer Technicon Immuno 1 System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 48th Annual Meeting, July 28-August 1, Chicago, IL. Clin Chem 1996;42:S233.

119.          Lévesque A., Letellier M., Dillon P.W., Grant A.M. Evaluation of the Estradiol Assay on the Bayer Technicon Immuno 1 System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 48th Annual Meeting, July 28-August 1, Chicago, IL. Clin Chem 1996;42:S232.

120.          Lévesque A., Letellier M., Dillon P.W., Grant, A.M. Evaluation of the Progesterone Assay on the Bayer Technicon Immuno 1 System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 48th Annual Meeting, July 28-August 1, Chicago, IL. Clin Chem 1996;42:S232.

121.          Després N., Hartl F.T., Letellier M., Lévesque A., Grant A.M.Evaluation of the Serum Folate Assay on the Technicon Immuno 1 System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 48th Annual Meeting, July 28-August 1, Chicago, IL. Clin Chem 1996;42:S126.

122.          Després N., Mattes-Pound M.L., Letellier M., Grant A.M. Evaluation of the Red Blood Cell Folate Assay on the Technicon Immuno 1 System. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 48th Annual Meeting, July 28-August 1, Chicago, IL. Clin Chem 1996;42:S125.

123.          Després N., Fortin C., Letellier M., Grant A.M. Spuriously High Concentration of Serum Free Thyroxine Due to Anti-Thyroxine Autoantibodies. American Association for Clinical Chemistry & Canadian Society of Clinical Chemists, 48th Annual Meeting, July 28-August 1, Chicago, IL. Clin Chem 1996;42:S311.

124.          Xhignesse M., Grant A.M., Delisle E., Niyonsenga T., Laplante P., Bernier R. Le projet FAMUS : Un registre de soins primaires québécois pour les facteurs de risque des maladies cardiovasculaires. Présentation orale, 7e Journée de la recherche en médecine familiale. Montréal, 24 avril 1995.

125.          Xhignesse M., Niyonsenga T., Delisle E., Laplante P., Grant A.M., Bernier R. Intervention des médecins et cessation du tabac : analyse des données du registre FAMUS. Présentation orale, 7eJournée de la recherche en médecine familiale. Montréal, 24 avril 1995.

126.          Xhignesse M., Niyonsenga T., Delisle E., Laplante P., Grant A.M., Bernier R. Physician interventions with respect to their smoking patients : analysis of data from the FAMUS register. Présentation par affiche, 37th Annual Scientific Assembly of the College of Family Physicians of Canada. Québec, Québec, 12-13 mai 1995.

127.          Laplante P., Vanasse A., Xhignesse M., Delisle E., Grant A.M., Bernier R. Monotherapy for hypertention : a cross-sectional analysis from the FAMUS provincial register. Présentation orale, Trillium Primary Care Research Forum. University of Western Ontario, London, Ontario, 27 mai 1995.

128.          Xhignesse M., Grant A.M., Delisle E., Niyonsenga T., Bernier R. Use of a primary care register for cardiovascular risk factors and disease. Acceptée pour une présentation orale, 2nd International Heart Health Conference. Barcelone, Espagne, 28 mai au 1er juin 1995.

129.          Niyonsenga T., Xhignesse M., Grant A.M., Delisle E. Applications of canonical ordination methods to epidemiological studies. Présentation orale, Canadian Society for Epidemiology and Biostatistics. St. John's, Newfoundland, 16-18 août 1995.

130.          Letellier M., Lévesque A., Daigle F., Grant A.Mévaluation de l'autoanalyseur Immuno 1 de Bayer Inc. SQBC Meeting, October 11-14, 1995.

131.          Lévesque A, Letellier M, Grant A.M. évaluation analytique des méthodes progestérone et estradiol sur l'autoanalyseur Immuno 1. SQBC Meeting, October 11-14, 1995.